Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 5.63x is 265% above its 5-year average of 1.54x, near the low end of its 5-year range (-8.68x–42.14x).
54.77% below its 12-month average of 12.45x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 42.14x.
INTEREST COVERAGE RATIO
5.63x
INTEREST COVERAGE RATIO AVG TTM
12.45x
INTEREST COVERAGE RATIO AVG 3Y
2.36x
INTEREST COVERAGE RATIO AVG 5Y
1.54x
INTEREST COVERAGE RATIO AVG 10Y
-0.27x
INTEREST COVERAGE RATIO AVG 15Y
-0.78x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-54.77%
CURRENT VS 3Y AVG
+138.37%
CURRENT VS 5Y AVG
+265.19%
CURRENT VS 10Y AVG
+2153.81%
CURRENT VS 15Y AVG
+825.43%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+187.42%
vs the sector median at left
Puma Biotechnology, Inc.
Market Cap
$483.54M
Interest Coverage Ratio
5.63x
TTM Avg
12.45x
3Y Avg
2.36x
5Y Avg
1.54x
Market Cap
$475.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.23M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$471.57M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$469.12M
Interest Coverage Ratio
-23.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$498.52M
Interest Coverage Ratio
-99.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$467.90M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | $483.54M | 5.63x | 12.45x | 2.36x | 1.54x |
| Evolus, Inc. (EOLS)vs › | $486.01M | -1.91x | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | -1.04x | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -23.91x | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $498.52M | -99.49x | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $467.90M | 30.36x | 30.37x | 18.36x | 29.15x |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 28.21x | 19.43x | 14.40x | 14.40x |
Interest Coverage
5.6x
Debt/Equity
0.03
Current Ratio
2.91
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 42.14x |
| 2026-03-31 | -5.24x |
| 2025-12-31 | 15.29x |
| 2025-09-30 | 6.43x |
| 2025-06-30 | 3.61x |
| 2025-03-31 | 1.83x |
| 2024-12-31 | 5.10x |
| 2024-09-30 | 7.12x |
| 2024-06-30 | -0.65x |
| 2024-03-31 | -0.68x |
| 2023-12-31 | 4.41x |
| 2023-09-30 | 2.57x |
| 2023-06-30 | 1.47x |
| 2023-03-31 | 1.32x |
| 2022-12-31 | 3.05x |
| 2022-09-30 | 0.81x |
| 2022-06-30 | 4.46x |
| 2022-03-31 | -0.28x |
| 2021-12-31 | -8.68x |
| 2021-09-30 | -2.87x |
| 2021-06-30 | -4.73x |
| 2021-03-31 | 5.84x |
| 2020-12-31 | -3.13x |
| 2020-09-30 | -3.34x |
| 2020-06-30 | 1.88x |
| 2020-03-31 | -4.65x |
| 2019-12-31 | -2.81x |
| 2019-09-30 | -4.72x |
| 2019-06-30 | -5.80x |
| 2019-03-31 | -2.27x |
| 2018-12-31 | -4.89x |
| 2018-09-30 | -3.23x |
| 2018-06-30 | -16.02x |
| 2018-03-31 | -21.68x |
| 2017-12-31 | -90.86x |
| 2015-12-31 | -195.90x |
| 2014-12-31 | -471.29x |
| 2012-12-31 | -621.40x |
| 2012-09-30 | -1791.30x |
| 2012-06-30 | -656.30x |
| 2012-03-31 | -462.31x |
